Preliminary results from first patient treated with OTL-201 show over expression of the therapeutic enzyme and decrease in substrate levels three months following gene therapy BOSTON and LONDON, Dec.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback